Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation

British Journal of Clinical Pharmacology
M M MitlerW C Dement


1 Temazepam was evaluated in a strictly defined insomniac patient population under sleep laboratory conditions. Two protocols were used: a short-term (26-night) and a long-term (54-night) protocol evaluated the efficacy of the drug administered at night at 15 mg (short-term study) and 30 mg (long-term study), respectively. 2 Temazepam seemed to be both safe and effective at doses of 15 and 30 mg with up to 5 weeks of ingestion. 3 Suppression of slow wave sleep was observed at the high dose, but no suppression of REM sleep, found in studies with other benzodiazepines, was noted. 4 No evidence was found for development of tolerance or rebound effects.


Sep 1, 1975·Clinical Pharmacology and Therapeutics·A KalesM B Scharf
Sep 15, 1978·Science·A KalesJ D Kales
Jul 1, 1971·Clinical Pharmacology and Therapeutics·J D KalesE S Slye


Jan 1, 1983·European Journal of Clinical Pharmacology·A Vela-BuenoA Kales
Jul 1, 1996·Psychopharmacology·Liborio Parrino, Mario Giovanni Terzano
Mar 15, 2005·General Hospital Psychiatry·Michael E Thase
Mar 9, 2004·Journal of Psychiatric Research·Dalva R PoyaresSergio Tufik
May 10, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Dalva R PoyaresSergio Tufik
Apr 27, 2012·Advances in Pharmacological Sciences·Christiaan H Vinkers, Berend Olivier
Jan 1, 1987·European Journal of Clinical Pharmacology·F O MüllerG C Dunbar
Jan 1, 1981·Anaesthesia·A P BeecheyC Studd
Jul 1, 1987·Journal of Clinical Pharmacology·A KalesR L Manfredi
Mar 1, 1985·Journal of Clinical Pharmacology·E O BixlerC R Soldatos
Nov 1, 1982·Journal of Clinical Pharmacology·A KalesJ D Kales
Jun 1, 1984·British Journal of Clinical Pharmacology·T RoehrsT Roth
Jun 29, 1999·Otolaryngologic Clinics of North America·W H Obermeyer, R M Benca
Sep 25, 2003·Sleep Medicine Reviews·Shawn D Youngstedt
Nov 10, 2009·Sleep Medicine Reviews·Merijn van de LaarSebastiaan Overeem
Sep 10, 2010·Schizophrenia Research·Sukanto SarkarSamir Kumar Praharaj
Jul 15, 2009·Sleep Medicine·Liborio ParrinoMario Giovanni Terzano
Apr 13, 2004·International Clinical Psychopharmacology·S J WilsonD J Nutt
Jan 18, 2003·Human Psychopharmacology·Charles M MorinTimothy R Brown
Mar 7, 2006·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Russell P Rosenberg
Aug 1, 1982·The British Journal of Venereal Diseases·O V CalubiranB M Limson
Feb 1, 1991·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·E Teboul, G Chouinard
Jan 25, 1990·The New England Journal of Medicine·J C Gillin, W F Byerley
Jul 1, 1981·Pharmacotherapy·M M Mitler
Jan 1, 1981·British Journal of Clinical Pharmacology·A N Nicholson
Sep 1, 1990·Hospital Practice·A Kales
Sep 1, 1982·Drug Intelligence & Clinical Pharmacy·J C McElnayB Alexander
Mar 1, 1980·British Journal of Clinical Pharmacology·A N Nicholson

Related Concepts

Clinical Trials
Drug Tolerance
Sedative Effect
Transient Insomnia
Sleep, REM
Pfizer Brand 1 of Temazepam
Anti-Anxiety Effect
Substance-Related Disorders

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Computational Methods for Protein Structures

Computational methods employing machine learning algorithms are powerful tools that can be used to predict the effect of mutations on protein structure. This is important in neurodegenerative disorders, where some mutations can cause the formation of toxic protein aggregations. This feed follows the latests insights into the relationships between mutation and protein structure leading to better understanding of disease.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.